Inception Growth Acquisition Limited (IGTA)
NASDAQ: IGTA · IEX Real-Time Price · USD
11.34
+0.01 (0.09%)
Jul 2, 2024, 1:21 PM EDT - Market closed
Company Description
Inception Growth Acquisition Limited does not have significant operations.
The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.
It intends to focus on sourcing opportunities in the technology, media and telecom, sports and entertainment, and non-gambling game sectors.
The company was incorporated in 2021 and is based in New York, New York.
Inception Growth Acquisition Limited
| Country | United States |
| Founded | 2021 |
| IPO Date | Dec 9, 2021 |
| Industry | Shell Companies |
| Sector | Financials |
| CEO | Cheuk Hang Chow |
Contact Details
Address: 875 Washington Street New York, New York 10014 United States | |
| Phone | 315-636-6638 |
Stock Details
| Ticker Symbol | IGTA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 0001866838 |
| CUSIP Number | 45333D104 |
| ISIN Number | US45333D1046 |
| Employer ID | 86-2648456 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Cheuk Hang Chow | Chief Executive Officer and Chairman |
| Felix Wong | Chief Financial Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 21, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 21, 2024 | 8-K | Current Report |
| Jun 10, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 10, 2024 | 8-K | Current Report |
| Jun 3, 2024 | 10-K/A | [Amend] Annual report |
| May 20, 2024 | 10-Q | Quarterly Report |
| May 17, 2024 | 8-K | Current Report |
| May 15, 2024 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
| May 13, 2024 | DEF 14A | Other definitive proxy statements |
| May 8, 2024 | 8-K | Current Report |